CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
104.57
0.48%
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.46
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022099 %
Charges from full value of position ($-4.20)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022099%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000123 %
Charges from full value of position ($-0.02)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000123%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5%
Stock exchange France
Commission on trade 0%

*Information provided by Capital.com

Ipsen SA ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 104.87
Open* 104.57
1-Year Change* -4.64%
Day's Range* 103.97 - 104.67
52 wk Range 94.85-130.70
Average Volume (10 days) 89.99K
Average Volume (3 months) 1.61M
Market Cap 8.89B
P/E Ratio 21.67
Shares Outstanding 82.64M
Revenue 3.28B
EPS 4.90
Dividend (Yield %) 1.13101
Beta 0.59
Next Earnings Date Feb 8, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 23, 2024 104.57 1.10 1.06% 103.47 104.67 103.27
Feb 22, 2024 104.87 1.00 0.96% 103.87 105.37 101.77
Feb 21, 2024 103.27 0.90 0.88% 102.37 104.07 101.57
Feb 20, 2024 105.37 -0.50 -0.47% 105.87 107.47 105.27
Feb 19, 2024 105.87 1.70 1.63% 104.17 106.17 104.17
Feb 16, 2024 104.57 -0.20 -0.19% 104.77 108.37 104.47
Feb 15, 2024 104.67 1.10 1.06% 103.57 105.67 103.17
Feb 14, 2024 102.87 0.10 0.10% 102.77 104.97 101.87
Feb 13, 2024 102.77 0.40 0.39% 102.37 104.27 99.97
Feb 12, 2024 103.27 -3.30 -3.10% 106.57 107.87 103.27
Feb 9, 2024 107.47 1.70 1.61% 105.77 109.46 105.77
Feb 8, 2024 105.47 -1.00 -0.94% 106.47 106.57 100.07
Feb 7, 2024 106.57 0.00 0.00% 106.57 107.17 105.97
Feb 6, 2024 106.37 0.80 0.76% 105.57 106.77 105.27
Feb 5, 2024 105.77 2.10 2.03% 103.67 106.67 103.67
Feb 2, 2024 105.77 0.20 0.19% 105.57 106.97 105.17
Feb 1, 2024 105.37 -1.20 -1.13% 106.57 107.17 105.37
Jan 31, 2024 106.67 2.20 2.11% 104.47 107.37 104.47
Jan 30, 2024 105.57 -2.20 -2.04% 107.77 108.87 105.57
Jan 29, 2024 107.27 0.00 0.00% 107.27 107.87 106.87

Ipsen Events

Time (UTC) Country Event
Tuesday, February 27, 2024

Time (UTC)

10:59

Country

FR

Event

Ipsen SA Non-Deal Roadshow - Paris
Ipsen SA Non-Deal Roadshow - Paris

Forecast

-

Previous

-
Wednesday, February 28, 2024

Time (UTC)

10:59

Country

FR

Event

Ipsen SA at UBS European Healthcare Conference (Virtual)
Ipsen SA at UBS European Healthcare Conference (Virtual)

Forecast

-

Previous

-
Thursday, April 25, 2024

Time (UTC)

05:00

Country

FR

Event

Q1 2024 Ipsen SA Corporate Sales Release
Q1 2024 Ipsen SA Corporate Sales Release

Forecast

-

Previous

-
Tuesday, May 28, 2024

Time (UTC)

10:59

Country

FR

Event

Ipsen SA Annual Shareholders Meeting
Ipsen SA Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 3156.4 2748.6 2686.2 2692.8 2348.4
Revenue 3156.4 2748.6 2686.2 2692.8 2348.4
Cost of Revenue, Total 527.7 438.6 490.6 488 454.2
Gross Profit 2628.7 2310 2195.6 2204.8 1894.2
Total Operating Expense 2423.9 1920.8 2157.6 2728.1 1829.1
Selling/General/Admin. Expenses, Total 1039.2 916.3 971.8 1020 953.1
Research & Development 445.3 424.4 405.6 388.8 302.1
Unusual Expense (Income) 138.6 25.6 191.9 698.4 37
Other Operating Expenses, Total 273.1 115.9 97.7 132.9 82.7
Operating Income 732.5 827.8 528.6 -35.3 519.3
Interest Income (Expense), Net Non-Operating -9.3 -22.7 -13.1 -32.6 -8.9
Other, Net -17.3 -16 13.3 29.3 -16.4
Net Income Before Taxes 705.9 789.1 528.8 -38.6 494
Net Income After Taxes 593.6 630.8 546.6 -58.2 385.9
Minority Interest 1.1 -0.1 -0.9 -0.5 0.4
Equity In Affiliates -1.5 0.4 -1.5 3.7 1.1
Net Income Before Extra. Items 593.2 631.1 544.2 -55 387.4
Total Extraordinary Items 55.4 15.5 3.8 4.2 2
Net Income 648.6 646.6 548 -50.8 389.4
Total Adjustments to Net Income 0.1 0.1
Income Available to Common Excl. Extra. Items 593.2 631.1 544.2 -54.9 387.5
Income Available to Common Incl. Extra. Items 648.6 646.6 548 -50.7 389.5
Diluted Net Income 648.994 646.861 548 -50.7 389.5
Diluted Weighted Average Shares 83.0978 83.3584 83.4481 83.095 83.2265
Diluted EPS Excluding Extraordinary Items 7.14332 7.57406 6.52142 -0.66069 4.65597
Dividends per Share - Common Stock Primary Issue 1.2 1.2 1 1 1
Diluted Normalized EPS 8.54588 7.81956 8.01618 4.80245 5.00326
Dilution Adjustment 0.39417 0.26139
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total revenue 1623.1 1658.5 1497.9 1452.3 1414.6
Revenue 1623.1 1658.5 1497.9 1452.3 1414.6
Cost of Revenue, Total 269.9 285.6 242.1 235.1 250.6
Gross Profit 1353.2 1372.9 1255.8 1217.2 1164
Total Operating Expense 1327.5 1439.8 996.6 1027.3 1002.4
Selling/General/Admin. Expenses, Total 552.7 551.9 487.3 488.2 483.4
Research & Development 290.2 238.1 207.2 219.3 207.3
Unusual Expense (Income) 29.5 137.5 3.7 23.5 4
Other Operating Expenses, Total 185.2 226.7 56.3 61.2 57.1
Operating Income 295.6 218.7 501.3 425 412.2
Interest Income (Expense), Net Non-Operating -12 -9 -9.5 -10.5 -11.4
Other, Net -22.1 4.9 -0.5 -13.9 0.1
Net Income Before Taxes 261.5 214.6 491.3 400.6 400.9
Net Income After Taxes 205.5 210.8 382.8 337.5 301.9
Minority Interest 0.1 1.1 0 -0.8 -0.7
Equity In Affiliates -10.3 -1 -0.5 0.3 0.1
Net Income Before Extra. Items 195.3 210.9 382.3 337 301.3
Total Extraordinary Items 0 43.3 12.1 5.5 1.2
Net Income 195.3 254.2 394.4 342.5 302.5
Total Adjustments to Net Income -0.1 0.1 -0.1 0.1 1.5
Income Available to Common Excl. Extra. Items 195.2 211 382.2 337.1 302.8
Income Available to Common Incl. Extra. Items 195.2 254.3 394.3 342.6 304
Diluted Net Income 195.2 254.694 394.3 342.861 304
Diluted Weighted Average Shares 83.0638 83.01 83.1857 82.9703 83.5165
Diluted EPS Excluding Extraordinary Items 2.35 2.54661 4.59454 4.06605 3.62563
Dividends per Share - Common Stock Primary Issue 0 1.2 0 1.2 0
Diluted Normalized EPS 2.62909 4.17371 4.6292 4.30467 3.6617
Dilution Adjustment 0.39417 0.26139
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 2397.6 1953.8 1578.8 1346.5 1185.6
Cash and Short Term Investments 1200.3 826.4 691.4 412.6 350
Cash 814.7 642.5 215.4 137.4
Cash & Equivalents 1169.3 137.9 207.1
Short Term Investments 31 11.7 48.9 59.3 5.5
Total Receivables, Net 673.7 764.5 602.8 644 560.1
Accounts Receivable - Trade, Net 632.5 564.3 476.2 565 463
Total Inventory 284.1 219.4 213.9 214 198.5
Prepaid Expenses 77.8 52.2 54.4
Other Current Assets, Total 239.5 65.7 70.7 23.7 22.6
Total Assets 5614.6 4990.5 4313 4306.9 3377.4
Property/Plant/Equipment, Total - Net 581.4 647.5 646.6 679.3 474.5
Property/Plant/Equipment, Total - Gross 1058.7 1290 1196.5 1170.7 934.5
Accumulated Depreciation, Total -477.3 -642.5 -549.9 -491.4 -460
Goodwill, Net 579.9 623.2 592.8 632.6 395.6
Intangibles, Net 1585.4 1370 1121.1 1383.2 1011.9
Long Term Investments 136.3 133.2 126.7 111.4 173.6
Other Long Term Assets, Total 334 262.8 247 153.9 136.2
Total Current Liabilities 1335.4 1228.4 1213.1 1452.5 959.2
Accounts Payable 647.1 594.7 495.2 508.5 379.8
Accrued Expenses 254.2 200.5 206.9 185.4
Notes Payable/Short Term Debt 3.8 5.5 2.8 14.3 33.6
Current Port. of LT Debt/Capital Leases 27.7 29.8 228.9 302.6 4.1
Other Current Liabilities, Total 656.8 344.2 285.7 420.2 356.3
Total Liabilities 2270.6 2255.3 2181.9 2555.8 1536.3
Total Long Term Debt 663.8 657.8 639.1 696.3 297.9
Long Term Debt 581.8 562.8 542.7 568.2 297.9
Deferred Income Tax 77.9 101.8 79.9 107.7 19.7
Minority Interest -0.6 2.5 2.7 2 2.3
Other Liabilities, Total 194.1 264.8 247.1 297.3 257.2
Total Equity 3344 2735.2 2131.1 1751.1 1841.1
Common Stock 83.8 83.8 83.8 83.8 83.8
Additional Paid-In Capital 122.3 122.3 122.3 741.9 741.7
Retained Earnings (Accumulated Deficit) 3193.5 2635.9 2121.1 973.3 1105.6
Treasury Stock - Common -107.2 -123.1 -102.1 -72.5 -63.3
Other Equity, Total 51.6 16.3 -94 24.6 -26.7
Total Liabilities & Shareholders’ Equity 5614.6 4990.5 4313 4306.9 3377.4
Total Common Shares Outstanding 82.6392 82.497 82.7225 83.0373 83.0651
Capital Lease Obligations 82 95 96.4 128.1
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total Current Assets 1759.8 2397.6 2589 1953.8 1764.2
Cash and Short Term Investments 438.1 1200.3 1123.2 826.4 739.6
Cash & Equivalents 413.4 1169.3 1068.3 814.7 737.5
Short Term Investments 24.7 31 54.9 11.7 2.1
Total Receivables, Net 685.6 673.7 716.1 687.1 646.3
Accounts Receivable - Trade, Net 649.4 632.5 623.8 564.3 554.6
Total Inventory 350 284.1 190.1 219.4 232.7
Other Current Assets, Total 286.1 239.5 559.6 220.9 145.6
Total Assets 6090.6 5614.6 5507.1 4990.5 4521.5
Property/Plant/Equipment, Total - Net 571.6 581.4 585.9 647.5 645.7
Property/Plant/Equipment, Total - Gross 1089.6 1058.7 1088.2 1290 1239.3
Accumulated Depreciation, Total -518 -477.3 -502.4 -642.5 -593.6
Goodwill, Net 681 579.9 557.4 623.2 604.4
Intangibles, Net 2547.9 1585.4 1373.1 1370 1142.4
Long Term Investments 111.8 136.3 118.7 133.2 128.8
Other Long Term Assets, Total 418.5 334 283 262.8 236
Total Current Liabilities 1709.8 1335.4 1374.2 1228.4 1117
Accounts Payable 746.6 647.1 577.8 594.7 518.6
Notes Payable/Short Term Debt 1.2 3.8 30.6 5.5 11.5
Current Port. of LT Debt/Capital Leases 178.1 27.7 29.3 29.8 180.4
Other Current Liabilities, Total 783.9 656.8 736.5 598.4 406.5
Total Liabilities 2686.3 2270.6 2442.6 2255.3 2134.9
Total Long Term Debt 345.4 663.8 671.8 657.8 640.8
Long Term Debt 274.7 581.8 584.3 562.8 550.2
Capital Lease Obligations 70.7 82 87.5 95 90.6
Deferred Income Tax 297.6 77.9 120.7 101.8 92.1
Minority Interest -1 -0.6 1.6 2.5 1.7
Other Liabilities, Total 334.5 194.1 274.3 264.8 283.3
Total Equity 3404.3 3344 3064.5 2735.2 2386.6
Common Stock 83.8 83.8 83.8 83.8 83.8
Additional Paid-In Capital 122.3 122.3 122.3 122.3 122.3
Retained Earnings (Accumulated Deficit) 3265.1 3193.5 2896.3 2635.9 282
Treasury Stock - Common -86.1 -107.2 -102.3 -123.1 -100.5
Other Equity, Total 19.2 51.6 64.4 16.3 1999
Total Liabilities & Shareholders’ Equity 6090.6 5614.6 5507.1 4990.5 4521.5
Total Common Shares Outstanding 82.6392 82.6392 82.497 82.497 82.7225
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 647.5 646.7 548.9 -50.2 389.1
Cash From Operating Activities 973.3 917.4 771.3 627.7 570.9
Cash From Operating Activities 336.5 246.4 234.7 161.2 142.6
Deferred Taxes -136.3 -130.6 19.2
Non-Cash Items 159.2 219.7 134 626.9 22.8
Changes in Working Capital -169.9 -195.4 -10 20.4 -2.8
Cash From Investing Activities -458.6 -332 -163.7 -1157.3 -274.3
Capital Expenditures -252.9 -417.9 -140.7 -280.6 -287.5
Other Investing Cash Flow Items, Total -205.7 85.9 -23 -876.7 13.2
Cash From Financing Activities -164.2 -421.8 -307.5 550 -202.2
Financing Cash Flow Items -19.1 -22.6 -3.9 6.5 -1.2
Total Cash Dividends Paid -99.3 -82.9 -83.2 -83.2 -83
Issuance (Retirement) of Stock, Net -11.3 -36.7 -36.4 -16.7 -7.7
Issuance (Retirement) of Debt, Net -34.5 -279.6 -184 643.4 -110.3
Foreign Exchange Effects 5.9 5.8 0.5 7.7 7.3
Net Change in Cash 356.4 169.4 300.6 28.1 101.7
Cash Taxes Paid 130.7 181.1
Cash Interest Paid 18.2 21.5
Dec 2022 Jun 2022 Dec 2021 Jun 2021
Net income/Starting Line 647.5 394.3 646.7 303.3
Cash From Operating Activities 973.3 334.3 917.4 357.2
Cash From Operating Activities 336.5 105.8 246.4 110.3
Deferred Taxes 5.6 31.1
Non-Cash Items 159.2 -107.4 219.7 10.2
Changes in Working Capital -169.9 -64 -195.4 -97.7
Cash From Investing Activities -458.6 -178.6 -332 -77.6
Capital Expenditures -252.9 -117.9 -417.9 -78.6
Other Investing Cash Flow Items, Total -205.7 -60.7 85.9 1
Cash From Financing Activities -164.2 40.9 -421.8 -194.6
Financing Cash Flow Items -19.1 -3.3 -22.6 -2.9
Total Cash Dividends Paid -99.3 -99.3 -82.9 -82.9
Issuance (Retirement) of Stock, Net -11.3 -6.5 -36.7 -5.8
Issuance (Retirement) of Debt, Net -34.5 150 -279.6 -103
Foreign Exchange Effects 5.9 31.9 5.8 1.4
Net Change in Cash 356.4 228.5 169.4 86.4
Cash Taxes Paid 130.7 181.1
Cash Interest Paid 18.2 21.5
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Mayroy SA Corporation 56.6223 47457736 0 2022-12-31 LOW
Parvus Asset Management Europe Limited Investment Advisor/Hedge Fund 5.056 4237680 47337 2023-04-27 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.1881 995780 748 2023-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.0031 840782 20066 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.9999 838089 -3321 2023-09-30 LOW
Oddo BHF Asset Management S.A.S Investment Advisor/Hedge Fund 0.998 836459 55248 2023-09-30 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.5822 487971 -2828 2023-09-30 LOW
Black Creek Investment Management, Inc. Investment Advisor 0.3742 313611 -25493 2023-06-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.3711 311058 3005 2023-09-30 LOW
Liontrust Investment Partners LLP Investment Advisor 0.3711 311011 13076 2023-08-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.3216 269542 7 2023-09-30 LOW
Ipsen S.A. Employees Corporation 0.2802 234860 -38994 2022-12-31 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.2321 194517 2096 2023-09-30 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.2172 182043 0 2023-08-31 LOW
Goldman Sachs Asset Management, L.P. Investment Advisor 0.2142 179541 342 2023-09-30 LOW
Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund 0.2103 176249 0 2023-09-30 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.202 169285 3005 2023-09-30 LOW
M&G Investment Management Ltd. Investment Advisor 0.1908 159882 -12698 2023-07-31 LOW
CPP Investment Board Pension Fund 0.1873 157000 157000 2023-03-31 LOW
Florida State Board of Administration Pension Fund 0.184 154185 65455 2022-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Ipsen Company profile

Founded in 1929, Ipsen (IPN) is a leading international biopharmaceutical group, focusing on specialty care. The company develops and produces innovative medicines in 3 major areas: rare diseases, neurosciences and oncology. Ipsen also runs a consumer healthcare business. In general, the company sells over 20 drugs in more than 115 countries worldwide. Ipsen's R&D is focused on its differentiated and innovative technological platforms in the leading biotechnological hubs, based in Cambridge, the US, Oxford, the UK, and Paris-Saclay, France. Headquartered in Paris, the company employs 5,100 specialists. Included to the CAC Mid 60 index, the Ipsen share price (IPN) is set and traded on the Euronext Paris exchange.
Industry: Pharmaceuticals (NEC)

65 Quai Georges Gorse
BOULOGNE-BILLANCOURT
ILE-DE-FRANCE 92100
FR

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

US100

17,914.30 Price
-0.300% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 7.0

Gold

2,035.76 Price
+0.560% 1D Chg, %
Long position overnight fee -0.0185%
Short position overnight fee 0.0103%
Overnight fee time 22:00 (UTC)
Spread 0.50

XRP/USD

0.55 Price
+0.780% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Oil - Crude

76.56 Price
-2.240% 1D Chg, %
Long position overnight fee 0.0163%
Short position overnight fee -0.0382%
Overnight fee time 22:00 (UTC)
Spread 0.030

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading